Trials / Recruiting
RecruitingNCT05839834
Blood Cell RNA-Based Cancer Detection
A Blinded Prospective Study on Development and Validation of the Blood Cell RNA-Based Cancer Detection
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
Early diagnosis of cancer may provide patients with more treatment options and hopefully prolong survival. The purpose of this multi-center study is to collect peripheral blood from newly diagnosed cancer patients and healthy donors to establish a blood cell RNA-based model for the differentiation of cancer patients and healthy donors. The area under the receiver operating characteristic (AUROC), sensitivity and specificity of the test in the early detection of multiple cancers will be measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood test | RNA sequencing of peripheral blood cells |
Timeline
- Start date
- 2021-02-08
- Primary completion
- 2024-11-01
- Completion
- 2024-12-08
- First posted
- 2023-05-03
- Last updated
- 2024-07-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05839834. Inclusion in this directory is not an endorsement.